Cargando…
The effect of anticoagulation on clinical outcomes in novel Coronavirus (COVID-19) pneumonia in a U.S. cohort
BACKGROUND: COVID-19 infection is associated with D-dimer elevations, high rates of thrombus formation, and poor clinical outcomes. We sought to determine if empiric therapeutic anticoagulation (AC) affected survival in COVID-19 patients compared to standard prophylactic AC. METHODS: Retrospective a...
Autores principales: | Lynn, Lei, Reyes, Juan A., Hawkins, Katrina, Panda, Arjun, Linville, Laura, Aldhahri, Walaa, Kango, Ghazal, Shah, Sneha, Ayanian, Shant, Teufel, Karolyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7644262/ https://www.ncbi.nlm.nih.gov/pubmed/33186849 http://dx.doi.org/10.1016/j.thromres.2020.10.031 |
Ejemplares similares
-
The association between biomarkers and clinical outcomes in novel coronavirus pneumonia in a US cohort
por: Ayanian, Shant, et al.
Publicado: (2020) -
Lipid Biomarkers Associated with Mortality in COVID-19
por: Teufel, Karolyn, et al.
Publicado: (2021) -
Therapeutic anticoagulation in COVID-19 patients
por: Belfaqeeh, O., et al.
Publicado: (2021) -
When to use anticoagulation in COVID-19()()
por: Moll, Matthew, et al.
Publicado: (2021) -
Therapeutic anticoagulation in COVID-19 patients
por: Lemos, Anna Cristina Bertoldi, et al.
Publicado: (2021)